Important legal notice
Contact   |   Search on Europa   

Infectious Diseases Graphic element print icon Graphic element
  Homepage
Graphic element General information
  RTD Infectious Diseases Unit
  Developing countries
  EDCTP
   
Graphic element Projects
  About FP6 Funding
  FP6 projects
  About FP5 Funding
  FP5 projects
   
   
Graphic element Addressed Diseases
  HIV/AIDS
- News
  Malaria
  Tuberculosis
   
Graphic element Calls for proposals
  FP7 Calls
   
Graphic element Contact corner
  Unit
  Scientific officers
  Subscribe to our mailing list
   
 
ADVAC-EC
Coordination and Training Measures
Framework programme: 6
Call: 2
Project number:
LSSP-CT-2004-005106
EC contribution: € 390,000
Duration: 36 months
Type: SSA
Starting date: 16 December 2004
Website: http://www.advac.org
Graphic element Advanced Vaccinology Training for Scientists from ACC and Developing Countries: From Genomics to Vaccination Strategies for Communicable Diseases Linked to Poverty
Keywords: Internal cooperation; developing countries; ACC

Summary:

A two-week Advanced Course of Vaccinology will be organised annually from 2005 to 2007 at the Veyrier-du-Lac Conference Centre by Mérieux Foundation and University of Geneva.
The course will comprise top-level lectures, followed by interactive discussions and specific practical exercises in small working groups. Particular attention will be given to vaccines against HIV, tuberculosis and malaria. An important aspect of the course will be the promotion of contacts and international networks. Care will be taken to maintain a full independence from any influence of a commercial nature. English will be the official language.Each year, an international scientific committee will select 60 participants, including 30 from developing countries (DC), associated candidate countries (ACC), and East European countries; 20 out of the 30 will be from DC. Among them, the aim will be to select ten participants from sub-Saharan Africa. The course will be targeted at young professionals or those soon to be involved in vaccine-related research and strategic issues.
The course will also be co-sponsored by US-NIH, CDC, WHO, ESPID, University of Geneva, Johns Hopkins SPH and main vaccine producers, and they will provide lecturers. An independent evaluation is planned.
Funding from the EC will ensure that scientists from developing countries, associated candidate countries (ACC), Russia, other newly independent states (NIS), and the western Balkans will benefit from fellowships for travel, housing and registration. Other participants will be asked to contribute to course expenses (registration fee) with a reduced rate for academia and governmental agencies.

Aim:

The overall objective of this training is to create a critical mass of people, in Europe and in developing countries, with a sufficiently broad knowledge of vaccinology to be able to play a leading role in decision-making processes related to (i) pre-clinical vaccine research (go/no-go), (ii) design and monitoring of clinical trials, (iii) vaccine safety issues, (iv) selection of new and appropriate vaccination strategies, including economic aspects, and (v) communication.

Coordinator:

Paul-Henri Lambert
Fondation Mérieux
17, rue Bourgelat
BP 2021
69227 Lyon Cedex 02
France
Tel: +41 22 379 5783/5777
Fax: +41 22 379 5801
E-mail: paul.lambert@medecine.unige.ch
Website: http://www.advac.org

Partners:

Principal
Scientific
Participants
Official Address Other Information
2Claire-A. SiegristCMU- Centre of Vaccinology

1, rue Michel-Servet
CH1211- Geneva 4
Switzerland
Tel: +41 22 379 7522
Fax: +41 22 379 1180
E-mail:
claire-anne.siegrist@medecine.unige.ch

 
 
top
Graphic element